Clinical Trial Update: Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses evaluating personalized treatment guided by BRCA1 assessment in patients with advanced gastric cancer in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Advanced Gastric Cancer | Phase 2, Phase 3 | Status: UNKNOWN